Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 24/01/11

Trade details

Type: Insider sale
Amount: $95,383.53
Shares · price: 5,841 sh · $16.33 a share
Held after: 2,836,776 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Justin B. KleeCo-CEO
Trade date: 24/01/09
Filed: 24/01/11
Days to filing: 2 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/10~24/02/08

Justin B. Klee's recent trades

Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$423.7K
29,282 sh
$423.7K
Filed 03/04
Traded 03/02
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02